NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Koman,

I know this topic is not on your priority list, but just to follow through with this possible scenario under the new accelerated approval clause. I think that if the blind is continued after a halt recommendation is publicly announced, that means the halt recommendation was rejected by the company in favor of accelerated approval under that clause, which means, THEY CAN KEEP ENROLLING. When you were speaking in a prior post, you stated after the halt this could occur, but I think what you meant is after the halt recommendation. Regardless, if they can keep enrolling, then they will certainly have full enrollment before long because of the positive press from the halt recommendation announcement -- which I think is what you meant.